Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biofermin tablets for bowel management in elderly long-term care patients
jRCTs031210287Completed
- Sponsor
- Biofermin Pharmaceutical
- Start
- Aug 2021
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Lactasin in constipation, sponsored by Biofermin Pharmaceutical. Primary endpoint: Change in spontaneous bowel movements at 6 weeks. Started Aug 2021; status: completed.
02
Drugs
Lactasin
03
Conditions
constipation
Beyond the preview
Go deeper on jRCTs031210287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210287.